Using the Health Belief Model to test factors affecting patient retention in diabetes-related pharmaceutical care services

Research in Social and Administrative Pharmacy

Volumn 2, Issue 1, 2006, Pages 38-58

  Pinto, Sharrel L ^a   Lively, Buford T ^a   Siganga, Walter ^a   Holiday Goodman, Monica ^a   Kamm, Gayle ^a  

^a UNIVERSITY OF TOLEDO   (United States)

Author keywords

Diabetes; Health Belief Model; Patient perceptions; Patient retention; Pharmaceutical care

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; FACTORIAL ANALYSIS; FEMALE; HUMAN; HUMAN RELATION; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ATTITUDE; PHARMACIST; PHARMACY; QUESTIONNAIRE; REPRODUCIBILITY; THEORETICAL MODEL; UNITED STATES;

ADULT; AGED; COMMUNITY PHARMACY SERVICES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FACTOR ANALYSIS, STATISTICAL; FEMALE; FLORIDA; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; PATIENT ACCEPTANCE OF HEALTH CARE; PHARMACISTS; PROFESSIONAL-PATIENT RELATIONS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN;

EID: 33746424357     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2005.11.001     Document Type: Article

References (53)

1. Fast Stats A to Z, Centers for Disease Control and Prevention. Available from:. Accessed 05.10.05
2. Incidence of diabetes in United States. National Diabetes Information Clearinghouse. Available from:. Accessed 02.20.01
3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 (1993) 977-986
4. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
5. Epidemiology of Diabetes Interventions and Complications Research Group. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 290 (2003) 2159-2167
6. Healthy People 2010. Office of Disease Prevention and Health Promotion, US Department of Health and Human Services. Available from:. Accessed 02.10.05
7. Glasgow R.E., and Anderson R.M. In diabetes care, moving from compliance to adherence is not enough. Diabetes Care 22 (1999) 2090-2091
8. Campbell R.K. Role of the pharmacist in diabetes patient care. Diabetes Prof (1990) 20-23
9. Johnson L.C., and Beach E. The importance of the pharmacist's expanding role on the diabetes team: reinforcing nutritional guidelines for improved glycemic control. Pharm Pract Manag Q 17 (1997) 32-44
10. Erickson S.R., Slaughter R., and Halapy H. Pharmacists' ability to influence outcomes of hypertension therapy. Pharmacotherapy 17 (1997) 140-147
11. Sookaneknun P., Richards R., Sanguansermsri J., et al. Pharmacist involvement in primary care improves hypertensive patient clinical outcomes. Ann Pharmacother 38 (2004) 2023-2028
12. Vivian E. Improving blood pressure control in a pharmacist-managed hypertension clinic. Pharmacotherapy 22 (2002) 1533-1540
13. Garcao J.A., and Cabrita J. Evaluation of a pharmaceutical care program for hypertensive patients in rural Portugal. J Am Pharm Assoc 42 (2002) 858-864
14. Shibley M.C.H., and Pugh C.B. Community pharmacy program for patients with hyperlipidemia. Ann Pharmacother 31 (1997) 713-719
15. Simpson S.H., Johnson J.A., Biggs R.S., et al. Greater effect of enhanced pharmacist care on cholesterol management in patients with diabetes mellitus: a planned subgroup analysis of the Study of Cardiovascular Risk Intervention by Pharmacists. Pharmacotherapy 24 (2004) 389-394
16. Bluml B.M., McKenney J.M., and Cziraky M.J. Pharmaceutical care services and results in Project ImPACT: hyperlipidemia. J Am Pharm Assoc 40 (2000) 157-165
17. Cranor C.W., Bunting B.A., and Christensen D.B. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc 43 (2003) 173-184
18. Cranor C.W., and Christensen D.B. The Asheville Project: short-term outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc 43 (2003) 149-159
19. Zulkowski K., and Coon P. Patient perceptions and provider documentation of diabetes care in rural areas. Ostomy Wound Manage 51 (2005) 50-58
20. Assa-Eley M., and Kimberline C. Using interpersonal perception to characterize pharmacists' and patients' perceptions of the benefits of pharmaceutical care. Health Commun 17 (2005) 41-56
21. Kaplan R., and Davis W. Evaluating the costs and benefits of outpatient diabetes education and nutrition counseling. Diabetes Care 37 (1984) 633-643
22. Nau DP. A perceived value framework for explaining patients intentions to use pharmaceutical care service [Ph.D. dissertation]. University of Florida, Gainesville, 1997.
23. Larson R.A. Patients' willingness to pay for pharmaceutical care. J Am Pharm Assoc 40 (2000) 618-624
24. MacKinnon III G.E., and Mahrous H. Assessing consumers' interest in health care services offered in community pharmacies. J Am Pharm Assoc 42 (2002) 512-515
25. Lamb E. Can you MTM?. Pharm Today 11 (2005) 6
26. Walter F.M., and Emery J. 'Coming down the line'-patients' understanding of their family history of common chronic disease. Ann Fam Med 3 (2005) 405-414
27. Goode J., Nau D., and Layson-Wolf C. Diabetes and the pharmacist's role. Diabetes Management Services: A Pharmacist's Resource Guide (2004), American Pharmacists Association, Washington, DC 7-10
28. Strecher V.J., and Rosenstock I.M. The Health Belief Model. In: Glanz K., Lewis F.M., and Rimer B.K. (Eds). Health Behavior and Health Education (1997), Jossey-Bass Publishers, San Francisco, Calif 41-60
29. Janz N.K., and Becker M.H. The Health Belief Model: a decade later. Health Educ Q 11 (1984) 1-47
30. King J.B. The impact of patients perceptions of high blood pressure on attendance at screening, an extension of the Health Belief Model. Soc Sci Med 16 (1982) 1079-1091
31. Ho V., Yamal J.M., Atkinson E.N., et al. Predictors of breast and cervical screening in Vietnamese women in Harris County, Houston, Texas. Cancer Nurs 28 (2005) 119-129
32. Wai C.T., Wong M.L., Ng S., et al. Utility of the Health Belief Model in predicting compliance of screening in patients with chronic hepatitis B. Aliment Pharmacol Ther 21 (2005) 1255-1262
33. Swift C.S., Armstrong J.E., Beerman K.A., et al. Attitudes and beliefs about exercise among persons with non-insulin-dependent diabetes. Diabetes Educ 21 (1995) 533-540
34. Marshall P. 'Just one more...!' A study into the smoking attitudes and behaviour of patients following first myocardial infarction. Int J Nurs Stud 27 (1990) 375-387
35. Brown C.M., and Segal R. The effects of health and treatment perceptions on the use of prescribed medication and home remedies among African American and white American hypertensives. Soc Sci Med 43 (1996) 903-917
36. Wdowik M.J., Kendall P.A., Harris M.A., et al. Expanded Health Belief Model predicts diabetes self-management in college students. Soc Nutr Educ (2001) 17-23
37. Kelly G.R., Mamon J.A., and Scott J.E. Utility of the Health Belief Model in examining medication compliance among psychiatric outpatients. Soc Sci Med 25 (1987) 1205-1211
38. Werner P. Factors influencing intentions to seek a cognitive status examination: a study based on the Health Belief Model. Int J Geriatr Psychiatry 18 (2003) 787-794
39. Sullivan K.T., Pasch L.A., Cornelius T., et al. Predicting participation in premarital prevention programs: the Health Belief Model and Social Norms. Fam Process 43 (2004) 175-193
40. Algina J. Sample size tables for correlation analysis with applications in partial correlation and multiple regression analysis. Multivar Behav Res 38 (2003) 309-323
41. Hair J.F., Anderson R.E., Tathamet R.L., et al. Multivariate data analysis (1998), Prentice-Hall, Upper Saddle River, NJ 87-138
42. Stevens J. Applied multivariate statistics for the social sciences (2002), Lawrence Erlbaum Associates, Mahwah, NJ 6-395
43. Guadagnoli E., and Velicer W.F. Relation of sample size to the stability of component patterns. Psychol Bull 103 (1988) 265-275
44. US Census Bureau. Available from: (2000). Accessed 04.04.01
45. National Statistics. National Diabetes Information Clearing house. Available from:. Accessed 09.02.00
46. Svarstad B.L., and Bultman D.C. Effects of pharmacists monitoring on patient satisfaction with antidepressant medication therapy. J Am Pharm Assoc 42 (2002) 36-43
47. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 27 (2004) S15-S35
48. Lin H., Xirasagar S., and James L.N. Patient perceptions of service quality in group versus solo practice clinics. Int J Qual Health Care 16 (2004) 437-445
49. American Diabetes Association. National standards for diabetes self-management education. Diabetes Care 25 (2002) 140-147
50. Haugbolle L.S., Devantier K., and Frydenlund B. A user perspective on type 1 diabetes: sense of illness, search for freedom and the role of the pharmacy. Patient Educ Couns 47 (2002) 361-368
51. Garrett D.G., and Martin L.A. The Asheville Project: participants' perceptions of factors contributing to the success of a patient self-management diabetes program. J Am Pharm Assoc 43 (2003) 185-190
52. Kradjan W.A., Schulz R., Christensen D.B., et al. Patients' perceived benefit from and satisfaction with asthma-related pharmacy services. J Am Pharm Assoc 39 (1999) 658-666
53. Volume C.I., Farris K.B., Kassam R., et al. Pharmaceutical care research and education project: patient outcomes. J Am Pharm Assoc 41 (2001) 411-420